ISIN | LU2041627279 |
---|---|
Valor Number | 49491348 |
Bloomberg Global ID | |
Fund Name | JSS Sustainable Equity - Future Health Y USD acc |
Fund Provider |
J. Safra Sarasin Investmentfonds AG
Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com |
Fund Provider | J. Safra Sarasin Investmentfonds AG |
Representative in Switzerland |
J. Safra Sarasin Investmentfonds AG Basel Phone: +41 58 317 44 00 |
Distributor(s) |
Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD). The assets of the fund are mainly invested worldwide either directly (min. 67% of the SubFund’s assets) or indirectly in equity securities that offer an exposure to one or multiple emerging and transformational health trends. The Sub-Fund invests in leading companies and niche players whose products and services contribute to the improvement of health outcome and the dampening of rising healthcare costs. |
Peculiarities |
Current Price * | 117.46 USD | 12.06.2025 |
---|---|---|
Previous Price * | 116.55 USD | 11.06.2025 |
52 Week High * | 128.05 USD | 30.08.2024 |
52 Week Low * | 105.13 USD | 08.04.2025 |
NAV * | 117.46 USD | 12.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 135,849,377 | |
Unit/Share Assets *** | 5,617,196 | |
Trading Information SIX |
YTD Performance | +4.12% |
31.12.2024 - 12.06.2025
31.12.2024 12.06.2025 |
---|---|---|
YTD Performance (in CHF) | -7.06% |
31.12.2024 - 12.06.2025
31.12.2024 12.06.2025 |
1 month | +3.41% |
12.05.2025 - 12.06.2025
12.05.2025 12.06.2025 |
3 months | +0.09% |
12.03.2025 - 12.06.2025
12.03.2025 12.06.2025 |
6 months | +0.80% |
12.12.2024 - 12.06.2025
12.12.2024 12.06.2025 |
1 year | -3.09% |
12.06.2024 - 12.06.2025
12.06.2024 12.06.2025 |
2 years | -3.84% |
12.06.2023 - 12.06.2025
12.06.2023 12.06.2025 |
3 years | +5.94% |
13.06.2022 - 12.06.2025
13.06.2022 12.06.2025 |
5 years | +7.84% |
12.06.2020 - 12.06.2025
12.06.2020 12.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 9.82% | |
---|---|---|
Danaher Corp | 7.04% | |
Lonza Group Ltd | 5.42% | |
Siemens Healthineers AG Registered Shares | 5.23% | |
Sanofi SA | 5.19% | |
Intuitive Surgical Inc | 5.13% | |
Novo Nordisk AS Class B | 4.28% | |
AbbVie Inc | 4.23% | |
argenx SE | 4.16% | |
Zoetis Inc Class A | 3.83% | |
Last data update | 30.04.2025 |
TER | 0.95% |
---|---|
TER date | 31.10.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 0.98% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |